South Africa Breast Cancer Therapeutics Market Analysis

South Africa Breast Cancer Therapeutics Market Analysis


$ 3999

The South Africa breast cancer therapeutics market size was valued at $118 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. Increasing awareness initiatives for breast cancer by the government and new drug developments for the treatment of breast cancer are driving the South Africa breast cancer therapeutics market. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the major market players in the South Africa breast cancer therapeutics market are Dis-Chem Pharmacies, AstraZeneca, and Eisai.

ID: IN10ZAPH031 CATEGORY: Pharmaceuticals GEOGRAPHY: South Africa AUTHOR: Parul Choudhary

Buy Now

South Africa Breast Cancer Therapeutics Market Executive Analysis

The South Africa breast cancer therapeutics market size is at around $118 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. South Africa spends $15.03 Bn on health, an increase over the updated forecast of $14.87 Bn in 2021. This includes $6.12 Bn for district health services, $2.98 Bn for other health services, $2.56 Bn for services at the central hospital, $2.21 Bn for services at the provincial hospital, and $0.56 Bn for facilities management and upkeep. As expenditures for COVID-19 wind down, the health baseline would account for $44.36 Bn (or 13.8%) of the government of South Africa's consolidated total spending in the medium term, a slight decline from $15.03 Bn in 2022-23 to $14.95 Bn in 2024-25.

Breast cancer incidence in 2012 was estimated by the International Agency for Cancer Research (IARC) to range from 27 per 100 000 women in central Africa to 39 per 100 000 women in southern Africa. Although breast cancer seems to occur less frequently in Sub-Saharan Africa (SSA), overall survival rates are low there, with significant mortality rates noted in several contexts. In addition to other competing public health concerns, inadequate funding, and poor healthcare infrastructure have all been linked to the low survival of breast cancer patients in SSA. Neoadjuvant chemotherapy (NAC) vs. adjuvant chemotherapy (AC) in patients with advanced and early-stage breast cancer (ESBC) has advanced significantly, with several ground-breaking studies demonstrating definite survival advantages for newer regimens after radiation, lumpectomy, or mastectomy. Therapy is still very difficult because anthracyclines and taxanes do not enhance the prognosis of the disease. Increased advancements in the application of particular biomarkers have yielded noteworthy outcomes. In addition, different radiation approaches are employed to treat women with various stages of tumor development in South Africa.

Market Dynamics

Market Growth Drivers

Increased pharmaceutical drug development, government awareness-raising initiatives, rapid acceptance of new screening measures, and rising healthcare spending for the treatment of breast cancer are major market drivers for the South Africa breast cancer therapeutics market.

Market Restraints

Considering the rising cost of the advanced medicines used to treat breast cancer. Chemotherapy is the most expensive therapy due to the rising cost of the pharmaceuticals used in breast cancer treatment. Because of the higher cost, not everyone can opt for chemotherapy, which could lead to a drop in the South Africa breast cancer therapeutics market.

Competitive Landscape

Key Players

  • Aspen (ZAF)
  • Adcock Ingram (ZAF)
  • Nkunzi Pharmaceuticals (ZAF)
  • Dis-Chem Pharmacies (ZAF)
  • AstraZeneca
  • Eisai
  • Eli Lilly
  • Roche

Healthcare Policies and Regulatory Landscape

NHI (National Health Insurance) is a system for financing healthcare that aims to pool resources to give all South Africans, regardless of socioeconomic level, access to high-quality, reasonably priced personal health services based on their individual health requirements. All South Africans will have universal health coverage provided by NHI. This explicitly refers to insurance for one's financial stability. It will establish a single public health fund with enough funds to adequately plan for and efficiently address all population health requirements. The NHI offers a comprehensive range of services related to breast cancer detection, treatment, and management, including mammography, biopsies, and surgery. Depending on the specific policy and the degree of coverage selected by the policyholder, private insurance firms may give different levels of coverage and reimbursement. Some private health insurance plans might not fully cover the price of all breast cancer treatments, leaving the policyholder with some out-of-pocket expenses.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Breast Cancer Therapeutics Segmentation

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
    • Targeted Therapy
      • Ribociclib
      • Abemaciclib
      • Afinitor
      • Everolimus
      • Trastuzumab
      • Olaparib
      • Ado-Trastuzumab Emtansine
      • Palbociclib
      • Pertuzumab
      • Herceptin
      • Tykerb (Lapatinib)
      • Others
  • Hormonal Therapy
    • Selective Estrogen Receptor Modulators (SERMs)
    • Aromatase Inhibitors
    • Estrogen Receptor Downregulators (ERDs)
  • Chemotherapy
    • Taxanes
    • Anthracyclines
    • Anti-metabolites
    • Alkylating Agents
  • Immunotherapy

By Cancer Type (Revenue, USD Billion):

  • Hormone Receptor
  • HER+

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 02 February 2023
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up